Monthly Archives: February 2020

Wedbush Sticks to Their Buy Rating for Mr Cooper Group (COOP)

The company’s shares closed last Monday at $12.83. According to TipRanks.com, Coffey is a 3-star analyst with an average return of 2.3% and a 55.7% success rate. Coffey covers the Financial sector, focusing on stocks such as Gladstone Investment, PennyMac

ABM Industries (ABM) Gets a Buy Rating from Maxim Group

Maxim Group analyst Tate Sullivan maintained a Buy rating on ABM Industries (ABM – Research Report) today and set a price target of $43.00. The company’s shares closed last Monday at $32.92, close to its 52-week low of $31.81. According

Saturday’s Midday Movers: Invivo Therapeutics Holdings (NVIV), Clovis Oncology (CLVS), ACADIA Pharmaceuticals (ACAD), Continental Resources (CLR), Bluebird Bio (BLUE)

So far Saturday, February 29, NASDAQ is up 13.13% and the S&P is up 7.56%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Invivo Therapeutics Holdings (NVIV – Research Report), Clovis Oncology (CLVS

What Did This CEO Just Do with Personal Shares of BioLife Solutions (NASDAQ: BLFS)?

Yesterday, the President & CEO of BioLife Solutions (BLFS – Research Report), Michael Rice, sold shares of BLFS for $32.89K. In addition to Michael Rice, 4 other BLFS executives reported Sell trades in the last month. See today’s analyst top

A Director at Rexford Realty (NYSE: REXR) is Selling Shares

Yesterday, a Director at Rexford Realty (REXR – Research Report), Steven C. Good, sold shares of REXR for $114.8K. Following Steven C. Good’s last REXR Sell transaction on July 24, 2013, the stock climbed by 34.9%. In addition to Steven

The COB & CEO of Liquidity Services (NASDAQ: LQDT) is Buying Shares

Yesterday, the COB & CEO of Liquidity Services (LQDT – Research Report), William Angrick, bought shares of LQDT for $257.1K. This is Angrick’s first Buy trade following 7 Sell transactions. In addition to William Angrick, 2 other LQDT executives reported